APLS — APELLIS PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 1 家机构在其最新 13F 申报中持有 APLS(APELLIS PHARMACEUTICALS INC),合计申报市值 $10.18K,对应 248 股。按股数计算较上季度减持 47.3%(-223 股),申报市值环比下降 46.3%。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。
与上一季度相比,1 家减仓、335 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
APELLIS PHARMACEUTICALS INC(APLS)的主要机构持有人包括 BlackRock Inc、Avoro Capital Advisors LLC、Morgan Stanley,按 13F 申报市值在本页 635 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q2 2026 | 1 | 248 | $10.18K | -47.3% |
| Q1 2026 | 336 | 210.58M | $5.62B | +11.6% |
| Q4 2025 | 291 | 182.62M | $2.97B | -3.4% |
| Q3 2025 | 280 | 183.43M | $2.71B | -3.4% |
| Q2 2025 | 253 | 188.88M | $2.26B | +4.5% |
| Q1 2025 | 260 | 181.49M | $15.37B | +2.4% |
| Q4 2024 | 263 | 177.48M | $17.71B | +4.1% |
| Q3 2024 | 271 | 168.84M | $16.40B | +6.4% |
表内 8 个季度中,机构持股合计减少 100%(Q3 2024 → Q2 2026);单季变动最大的是 Q1 2026(+11.6%)。
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.54M | $544.59M | 0.02% | 增持 | |
| 12.22M | $491.70M | 5.98% | 持有 | |
| 10.04M | $404.01M | 0.03% | 增持 | |
| 6.84M | $275.37M | 0.01% | 增持 | |
| 6.21M | $249.69M | 0.11% | 增持 | |
| 5.40M | $217.43M | 0.01% | 新进 | |
| 5.25M | $211.21M | 2.88% | 新进 | |
| 4.77M | $191.85M | 0.01% | 新进 | |
| 4.53M | $182.34M | 2.98% | 减持 | |
| 4.18M | $168.32M | 0.68% | 增持 | |
| 3.69M | $148.25M | 1.48% | 减持 | |
| 3.55M | $142.82M | 1.83% | 新进 | |
| 3.52M | $141.55M | 3.62% | 减持 | |
| 2.27M | $91.14M | 0.04% | 增持 | |
| 2.08M | $83.50M | 0.01% | 增持 | |
| 1.98M | $79.66M | 0.03% | 增持 | |
| 1.92M | $77.14M | 0.26% | 增持 | |
| 1.34M | $53.75M | 0.01% | 增持 | |
| 1.25M | $50.41M | 2.66% | 新进 | |
| 1.24M | $49.74M | 0.21% | 新进 | |
| 1.20M | $48.36M | 0.09% | 新进 | |
| 1.19M | $47.91M | 0.00% | 增持 | |
| 1.19M | $47.89M | 0.39% | 增持 | |
| 44.49M | $47.16M | 1.89% | 增持 | |
| 1.14M | $45.86M | 0.04% | 新进 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.22M | $307.02M | 3.38% | 持有 | |
| 10.67M | $268.15M | 0.00% | 增持 | |
| 9.17M | $230.43M | 0.01% | 减持 | |
| 7.75M | $194.68M | 3.47% | 减持 | |
| 7.67M | $192.59M | 1.93% | 新进 | |
| 6.26M | $157.25M | 0.00% | 持有 | |
| 4.61M | $115.89M | 0.00% | 增持 | |
| 4.19M | $105.16M | 0.06% | 增持 | |
| 4.14M | $103.98M | 2.13% | 增持 | |
| 3.71M | $93.11M | 0.43% | 增持 | |
| 2.58M | $64.77M | 1.93% | 持有 | |
| 2.43M | $61.04M | 1.30% | 增持 | |
| 2.28M | $57.19M | 0.03% | 减持 | |
| 2.28M | $57.19M | 0.03% | 减持 | |
| 2.03M | $50.90M | 0.00% | 减持 | |
| 44.19M | $45.59M | 2.03% | 持有 | |
| 1.50M | $37.79M | 0.02% | 减持 | |
| 1.39M | $34.80M | 0.01% | 减持 | |
| 1.20M | $30.10M | 0.00% | 减持 | |
| 1.18M | $29.64M | 0.23% | 增持 | |
| 1.07M | $26.88M | 0.07% | 减持 | |
| 1.00M | $25.12M | 1.81% | 持有 | |
| 990.85K | $24.89M | 0.04% | 增持 | |
| 956.77K | $24.03M | 0.00% | 减持 | |
| 946.46K | $23.78M | 0.01% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.22M | $276.59M | 4.10% | 持有 | |
| 9.99M | $226.01M | 0.00% | 减持 | |
| 9.64M | $218.23M | 0.01% | 减持 | |
| 8.00M | $181.05M | 5.05% | 增持 | |
| 6.27M | $141.86M | 0.00% | 减持 | |
| 4.49M | $101.55M | 0.07% | 减持 | |
| 4.49M | $101.55M | 0.07% | 减持 | |
| 4.35M | $98.40M | 0.06% | 增持 | |
| 4.04M | $91.37M | 0.00% | 增持 | |
| 3.45M | $78.01M | 3.74% | 减持 | |
| 3.43M | $77.62M | 0.04% | 减持 | |
| 2.88M | $65.13M | 1.68% | 持有 | |
| 2.65M | $59.97M | 0.31% | 增持 | |
| 2.58M | $58.35M | 2.28% | 持有 | |
| 2.07M | $46.92M | 0.00% | 增持 | |
| 44.19M | $45.90M | 1.98% | 持有 | |
| 1.49M | $36.39M | 0.01% | 减持 | |
| 1.50M | $34.05M | 0.01% | 增持 | |
| 1.48M | $33.44M | 0.01% | 减持 | |
| 1.46M | $32.95M | 0.09% | 增持 | |
| 1.34M | $30.41M | 0.05% | 增持 | |
| 1.34M | $30.41M | 0.01% | 增持 | |
| 1.17M | $26.58M | 0.14% | 增持 | |
| 1.15M | $25.93M | 0.00% | 减持 | |
| 1.00M | $22.63M | 2.38% | 持有 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.22M | $211.57M | 3.71% | 持有 | |
| 11.90M | $205.92M | 12.60% | 持有 | |
| 10.15M | $175.78M | 0.00% | 持有 | |
| 9.75M | $168.81M | 0.01% | 增持 | |
| 7.00M | $121.17M | 3.90% | 增持 | |
| 6.40M | $110.87M | 0.00% | 增持 | |
| 5.98M | $103.45M | 0.09% | 增持 | |
| 5.98M | $103.45M | 0.09% | 增持 | |
| 4.74M | $81.97M | 0.05% | 增持 | |
| 3.56M | $61.67M | 0.00% | 减持 | |
| 2.88M | $49.82M | 1.54% | 增持 | |
| 2.70M | $46.82M | 0.07% | 增持 | |
| 2.66M | $46.08M | 0.03% | 增持 | |
| 2.58M | $44.63M | 2.31% | 持有 | |
| 44.19M | $44.04M | 2.27% | 持有 | |
| 2.43M | $42.00M | 0.01% | 减持 | |
| 2.37M | $40.98M | 0.01% | 增持 | |
| 2.00M | $34.54M | 0.00% | 增持 | |
| 1.60M | $28.59M | 0.01% | 增持 | |
| 1.50M | $25.90M | 0.01% | 减持 | |
| 1.35M | $23.41M | 0.12% | 减持 | |
| 1.30M | $22.48M | 0.06% | 增持 | |
| 1.12M | $19.41M | 0.77% | 减持 | |
| 1.04M | $18.07M | 0.01% | 增持 | |
| 1.00M | $17.31M | 2.02% | 新进 |
Q1 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.95M | $12.71B | 0.27% | 持有 | |
| 12.22M | $267.30M | 4.17% | 持有 | |
| 11.90M | $260.16M | 16.07% | 持有 | |
| 10.13M | $221.55M | 0.00% | 增持 | |
| 9.63M | $210.52M | 0.01% | 持有 | |
| 6.33M | $138.43M | 0.00% | 减持 | |
| 5.00M | $109.35M | 3.54% | 增持 | |
| 4.08M | $89.17M | 0.09% | 增持 | |
| 4.08M | $89.17M | 0.09% | 增持 | |
| 3.94M | $86.20M | 0.00% | 减持 | |
| 3.27M | $71.56M | 0.05% | 增持 | |
| 3.13M | $68.48M | 0.01% | 增持 | |
| 2.58M | $56.39M | 3.18% | 减持 | |
| 2.48M | $54.18M | 0.04% | 减持 | |
| 44.19M | $46.42M | 2.17% | 减持 | |
| 2.09M | $45.80M | 9.23% | 减持 | |
| 1.95M | $42.66M | 0.00% | 增持 | |
| 1.78M | $38.85M | 0.02% | 持有 | |
| 1.65M | $36.14M | 1.57% | 减持 | |
| 1.65M | $36.01M | 1.34% | 增持 | |
| 1.58M | $34.49M | 0.23% | 持有 | |
| 1.57M | $34.41M | 0.01% | 增持 | |
| 1.50M | $32.88M | 0.00% | 减持 | |
| 1.43M | $31.32M | 0.78% | 新进 | |
| 1.11M | $24.29M | 0.07% | 增持 |
新建仓(Q2 2026)
本季度没有基金新建该仓位。
完全清仓(较上季)
- BlackRock Inc 卖出 13.54M 股 · $544.59M
- Avoro Capital Advisors LLC 卖出 12.22M 股 · $491.70M
- Morgan Stanley 卖出 10.04M 股 · $404.01M
- STATE STREET CORP 卖出 6.84M 股 · $275.37M
- UBS Group AG 卖出 6.21M 股 · $249.69M
- VANGUARD PORTFOLIO MANAGEMENT LLC 卖出 5.40M 股 · $217.43M
- Pentwater Capital Management LP 卖出 5.25M 股 · $211.21M
- VANGUARD CAPITAL MANAGEMENT LLC 卖出 4.77M 股 · $191.85M
- Deep Track Capital, LP 卖出 4.53M 股 · $182.34M
- Point72 Asset Management 卖出 4.18M 股 · $168.32M
- RTW INVESTMENTS, LP 卖出 3.69M 股 · $148.25M
- HBK INVESTMENTS L P 卖出 3.55M 股 · $142.82M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IFP Advisors, Inc | 248 | 471 | 982 | 1.11K | 1.07K | 126 | 4.09K | 4.18K | 4.37K | 3.70K | 3.73K | 3.81K | — | — | — | — | — | — | — | — |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | 11.95M | 11.95M | 11.95M | 11.95M | 11.95M | 11.95M | 11.95M | 12.25M | 11.00M | — | — | — | — | — | — | — | — | — | — |
| EcoR1 Capital, LLC | — | — | — | 3.45M | 11.90M | 11.90M | 11.89M | 11.89M | 11.61M | 11.36M | 11.17M | 732.50K | — | — | — | — | — | — | — | — |
| Avoro Capital Advisors LLC | — | 12.22M | 12.22M | 12.22M | 12.22M | 12.22M | 12.22M | 11.11M | 11.11M | 11.11M | 11.11M | 11.11M | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | 10.67M | 9.99M | 10.15M | 10.13M | 10.05M | 9.82M | 9.81M | 9.51M | 9.56M | 9.47M | 9.40M | 9.53M | 9.21M | 9.03M | 8.73M | 8.57M | 7.92M | 6.75M |
| BlackRock Inc | — | 13.54M | 6.26M | 6.27M | 6.40M | 6.33M | 6.48M | 6.19M | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | — | 10.04M | 9.17M | 9.64M | 9.75M | 9.63M | 9.63M | 3.39M | 2.12M | 1.64M | 3.10M | 1.61M | 756.66K | 752.86K | 299.88K | 223.28K | 453.02K | 253.39K | 67.66K | 8.00K |
| T. Rowe Price Investment Management, Inc. | — | 5.16K | 1.97K | 48.76K | 49.31K | 47.71K | 47.71K | 2.99M | 4.05M | 4.61M | 6.30M | 6.52M | — | — | — | — | — | — | — | — |
| STATE STREET CORP | — | 6.84M | 4.61M | 4.04M | 3.56M | 3.94M | 4.53M | 4.04M | 4.15M | 2.91M | 2.92M | 3.24M | — | — | — | — | — | — | — | — |
| UBS Group AG | — | 6.21M | 4.19M | 3.43M | 4.74M | 3.27M | 2.59M | 13.50K | 13.50K | 111.29K | 95.03K | 3.87K | 146.35K | 104.36K | 131.90K | 30.14K | 72.12K | 114.65K | 109.39K | 196.88K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | — | 5.40M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pentwater Capital Management LP | — | 5.25M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JENNISON ASSOCIATES LLC | — | — | 1.50M | 4.35M | 2.66M | 2.48M | 2.76M | 1.82M | 3.59M | 3.24M | 3.28M | 3.54M | — | — | — | — | — | — | — | — |
| Deep Track Capital, LP | — | 4.53M | 7.75M | 8.00M | 7.00M | 5.00M | 4.27M | 4.40M | 2.50M | 1.00M | — | — | — | — | — | — | — | — | — | — |
| RTW INVESTMENTS, LP | — | 3.69M | 7.67M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | — | 4.77M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Point72 Asset Management | — | 4.18M | 597.67K | 217.07K | — | — | 1.27M | — | — | 267.82K | — | — | 1.24M | 1.88M | — | — | — | 3.00M | 3.00M | 75.00K |
| Octagon Capital Advisors LP | — | — | — | 903.50K | 903.50K | 2.09M | 3.01M | 3.01M | 350.00K | 200.00K | 2.81M | 400.00K | — | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | — | 106.91K | 95.03K | 97.94K | 92.15K | 90.70K | 358.58K | 378.46K | 1.28M | 2.46M | 2.46M | 1.78M | — | — | — | — | — | — | — | — |
| HBK INVESTMENTS L P | — | 3.55M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
常见问题
Which funds hold APLS?
As of 2026-Q2, 1 institutional funds reported holding APLS (APELLIS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $10.18K.
How many shares of APLS do institutions own?
13F filers reported 248 shares of APLS, worth $10.18K in aggregate at the end of 2026-Q2.
Is institutional ownership of APLS rising or falling?
Share counts moved -47.3% versus the prior quarter — distribution.
Who are the top institutional holders of APLS?
The largest 13F holders are BlackRock Inc, Avoro Capital Advisors LLC, Morgan Stanley, STATE STREET CORP, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of APELLIS PHARMACEUTICALS INC?
The major shareholders of APELLIS PHARMACEUTICALS INC (APLS) by reported 13F value are BlackRock Inc, Avoro Capital Advisors LLC, Morgan Stanley, STATE STREET CORP, Vanguard Group, among 635 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.